Identification of a negative regulatory role for Spi-C in the murine B cell lineage

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3798-3807

  Li, Stephen K H ^a,b   Solomon, Lauren A ^a,b   Fulkerson, Patricia C ^c   De Koter, Rodney P ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR SPI B; TRANSCRIPTION FACTOR SPI C; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, MOUSE; SPI-B PROTEIN, MOUSE; SPIC PROTEIN, MOUSE;

ALLELE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; GENE REPRESSION; GENETIC CODE; GENETIC TRANSFECTION; GENOTYPE; MALE; MOUSE; NFKB1 GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPIC GENE; SPLEEN CELL; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; SPLEEN;

ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS C-ETS; SPLEEN;

EID: 84927654481     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402432     Document Type: Article

References (27)

1. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9:767-777.
2. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577.
3. Houston, I. B., M. B. Kamath, B. L. Schweitzer, T. M. Chlon, and R. P. DeKoter. 2007. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp. Hematol. 35:1056-1068.
4. Su, G. H., H. M. Chen, N. Muthusamy, L. A. Garrett-Sinha, D. Baunoch, D. G. Tenen, and M. C. Simon. 1997. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16:7118-7129.
5. Garrett-Sinha, L. A., G. H. Su, S. Rao, S. Kabak, Z. Hao, M. R. Clark, and M. C. Simon. 1999. PU.1 and Spi-B are required for normal B cell receptormediated signal transduction. Immunity 10:399-408.
6. Ray-Gallet, D., C. Mao, A. Tavitian, and F. Moreau-Gachelin. 1995. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11:303-313.
7. DeKoter, R. P., M. Geadah, S. Khoosal, L. S. Xu, G. Thillainadesan, J. Torchia, S. S. Chin, and L. A. Garrett-Sinha. 2010. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol. 185:7374-7384.
8. Sokalski, K. M., S. K. Li, I. Welch, H. A. Cadieux-Pitre, M. R. Gruca, and R. P. DeKoter. 2011. Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia. Blood 118:2801-2808.
9. Rothenberg, E. V. 2014. Transcriptional control of early T and B cell developmental choices. Annu. Rev. Immunol. 32:283-321.
10. Bemark, M., A. Mårtensson, D. Liberg, and T. Leanderson. 1999. Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development. J. Biol. Chem. 274:10259-10267.
11. Carlsson, R., C. Persson, and T. Leanderson. 2003. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus. Mol. Immunol. 39:1035-1043.
12. Carlsson, R., K. Thorell, D. Liberg, and T. Leanderson. 2006. SPI-C and STAT6 can cooperate to stimulate IgE germline transcription. Biochem. Biophys. Res. Commun. 344:1155-1160.
13. Schweitzer, B. L., K. J. Huang, M. B. Kamath, A. V. Emelyanov, B. K. Birshtein, and R. P. DeKoter. 2006. Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells. J. Immunol. 177:2195-2207.
14. Zhu, X., B. L. Schweitzer, E. J. Romer, C. E. Sulentic, and R. P. DeKoter. 2008. Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling. Eur. J. Immunol. 38:2587-2599.
15. Kohyama, M., W. Ise, B. T. Edelson, P. R. Wilker, K. Hildner, C. Mejia, W. A. Frazier, T. L. Murphy, and K. M. Murphy. 2009. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457:318-321.
16. Haldar, M., M. Kohyama, A. Y. So, W. Kc, X. Wu, C. G. Briseño, A. T. Satpathy, N. M. Kretzer, H. Arase, N. S. Rajasekaran, et al. 2014. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156:1223-1234.
17. Itoh-Nakadai, A., R. Hikota, A. Muto, K. Kometani, M. Watanabe-Matsui, Y. Sato, M. Kobayashi, A. Nakamura, Y. Miura, Y. Yano, et al. 2014. The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program. Nat. Immunol. 15:1171-1180.
18. Pfaffl, M. W., G. W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36.
19. Xu, L. S., K. M. Sokalski, K. Hotke, D. A. Christie, O. Zarnett, J. Piskorz, G. Thillainadesan, J. Torchia, and R. P. DeKoter. 2012. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia. J. Immunol. 189:3347-3354.
20. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225.
21. Pone, E. J., H. Zan, J. Zhang, A. Al-Qahtani, Z. Xu, and P. Casali. 2010. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit. Rev. Immunol. 30:1-29.
22. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321-330.
23. Li, S. K. H., A. K. Abbas, L. A. Solomon, G. M. N. Groux, and R. P. DeKoter. 2015. Nfkb1 activation by the ETS transcription factors PU.1 and Spi-B promotes toll-like receptor-mediated splenic B cell proliferation. Mol. Cell. Biol. DOI: 10.1128/MCB.00117-15.
24. Cogswell, P. C., R. I. Scheinman, and A. S. Baldwin. 1993. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J. Immunol. 150:2794-2804.
25. Kageyama, S., H. Liu, M. Nagata, and F. Aoki. 2006. The role of ETS transcription factors in transcription and development of mouse preimplantation embryos. Biochem. Biophys. Res. Commun. 344:675-679.
26. Claudio, E., K. Brown, S. Park, H. Wang, and U. Siebenlist. 2002. BAFFinduced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965.
27. Hu, C. J., S. Rao, D. L. Ramirez-Bergeron, L. A. Garrett-Sinha, S. Gerondakis, M. R. Clark, and M. C. Simon. 2001. PU.1/Spi-B regulation of c-rel is essential for mature B cell survival. Immunity 15:545-555.